Perioperative Pregabalin and Lidocaine to Reduce Chronic Breast Cancer Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Post-mastectomy Pain SyndromeChronic Post-surgical Pain
Interventions
DRUG

Intraoperative Intravenous Lidocaine Infusion

Lidocaine 1.5 mg/kg bolus with anesthesia induction followed by 2 mg/kg/hr infusion before the start of surgical incision and stopped at surgical closure.

DRUG

Perioperative Pregabalin

Pregabalin 300 mg preoperatively (e.g. 2 hours prior to the start of surgery) and 75 mg twice a day for 9 days after surgery.

DRUG

Perioperative Pregabalin Placebo

Pregabalin placebo 300 mg preoperatively (e.g. 2 hours prior to the start of surgery) and 75 mg twice a day for 9 days after surgery.

DRUG

Intraoperative Intravenous Lidocaine Placebo Infusion

Lidocaine placebo 1.5 mg/kg bolus with anesthesia induction followed by 2 mg/kg/hr infusion before the start of surgical incision and stopped at surgical closure.

Trial Locations (2)

L8V 1C3

Juravinski Hospital, Hamilton

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
collaborator

Hamilton Health Sciences Corporation

OTHER

lead

McMaster University

OTHER

NCT02240199 - Perioperative Pregabalin and Lidocaine to Reduce Chronic Breast Cancer Pain | Biotech Hunter | Biotech Hunter